Iron isomaltose
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Iron isomaltose, covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial [Phase 4]